^
Association details:
| Biomarker: | ALK translocation |
|---|---|
| Cancer: | Soft Tissue Sarcoma |
| Drug: | Alunbrig (brigatinib) (EGFR inhibitor, ALK inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/28/2021
Excerpt:
Soft Tissue Sarcoma: Inflammatory Myofibroblastic Tumor (IMT) with Anaplastic Lymphoma Kinase (ALK) Translocation...Preferred Regimen...Brigatinib
